4//SEC Filing
ALBANY MOLECULAR RESEARCH INC 4
Accession 0001638599-16-001632
CIK 0001065087operating
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:10 PM ET
Size
8.2 KB
Accession
0001638599-16-001632
Insider Transaction Report
Form 4
Hagen Steven R
VP Pharmaceutical Dev & Mfg
Transactions
- Sale
Common Stock
2016-11-30$16.71/sh−9,000$150,390→ 34,913 total - Exercise/Conversion
Common Stock
2016-11-30$13.20/sh+9,000$118,800→ 43,913 total - Exercise/Conversion
Option to Purchase Common Stock
2016-11-30$13.20/sh−9,000$118,800→ 0 totalExercise: $13.20Exp: 2018-11-03→ Common Stock (9,000 underlying)
Footnotes (1)
- [F1]Option grant was fully exercisable on November 3, 2012
Documents
Issuer
ALBANY MOLECULAR RESEARCH INC
CIK 0001065087
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001065087
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:10 PM ET
- Size
- 8.2 KB